✦ LIBER ✦

Phase I/II studies of combination chemotherapy with S-1 and platinum in patients with previously untreated metastatic or recurrent gastric cancer

✍ Scribed by Yoon-Koo Kang

Publisher: Springer
Year: 2009
Tongue: English
Weight: 184 KB
Volume: 12
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s10120-008-0472-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of irinotecan and docet

A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer

✍ Sun Jin Sym; Heung Moon Chang; Hye Jin Kang; Sung Sook Lee; Min-Hee Ryu; Jae-Lyu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 336 KB

Phase I/II study of 3-week combination o

Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer

✍ Jae-Lyun Lee; Hye Jin Kang; Yoon-Koo Kang; Min-Hee Ryu; Heung Moon Chang; Tae-Wo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 420 KB

Phase I study of 3-weekly docetaxel, cap

Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer

✍ Sun Jin Sym; Min-Hee Ryu; Hye Jin Kang; Sung Sook Lee; Heung-Moon Chang; Jae Lyu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 328 KB

Phase II study of S-1, docetaxel and cis

Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer

✍ Yasushi Sato; Tetsuji Takayama; Tamotsu Sagawa; Yasuo Takahashi; Hiroyuki Ohnuma 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 187 KB

Phase I study of cediranib in combinatio

Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer

✍ Taroh Satoh; Yasuhide Yamada; Kei Muro; Hidetoshi Hayashi; Yasuhiro Shimada; Dai 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 241 KB

Phase I/II study of S-1 combined with ca

Phase I/II study of S-1 combined with carboplatin in recurrent and/or metastatic head and neck cancer as outpatient chemotherapy

✍ Akihito Watanabe; Masanobu Taniguchi; Tetsuro Yamashita; Michihiro Ueda; Tatsuya 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Background. The aims of this study were to determine the recommended dose (RD) in combination chemotherapy of S‐1 and carboplatin in recurrent and/or metastatic head and neck cancer (phase I) and to examine response rate and toxicities at RD (phase II). ## Methods. S‐1 was given o